Skip to Content

    Heart disease causes one in four American deaths every year. Edwards Lifesciences, which creates artificial heart valves, including for patients deemed too risky for open surgery, has significantly expanded its international footprint and shows no signs of slowing down. The most promising growth avenue is among lower-risk patients who require noninvasive heart valve replacements.

    Subscribe to Fortune’s Brainstorm Health Daily newsletter, where we monitor advances in healthcare and biopharma.

    Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

    Company Information

    Overall Score1.6
    Sector
    Health Care
    Industry
    Health Care Equipment and Supplies
    CEO
    Michael Mussallem
    Websitehttps://www.edwards.com
    HQ Location
    Irvine, Calif.
    Country
    U.S.
    Revenues ($M) (Past 12 Months)$3,964
    Profits ($M) (Past 12 Months)$725
    Market Value as of Oct. 9, 2019 ($M)$46,754
    Employees12,800

    Refinitiv Sustainable Leadership Monitor